Data extracted from this reference:
Inhibitors
ppGpp
Staphylococcus aureus
Natural Substrates/ Products (Substrates)
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O
Staphylococcus aureus
2 AMP
?
Organism
Staphylococcus aureus
A0A0H2XFX6
USA300
Substrates and Products (Substrate)
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O
751077
Staphylococcus aureus
2 AMP
?
additional information
Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP
751077
Staphylococcus aureus
?
additional information
Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP
751077
Staphylococcus aureus USA300
?
Synonyms
SAUSA300_1650
Staphylococcus aureus
Inhibitors (protein specific)
ppGpp
Staphylococcus aureus
Natural Substrates/ Products (Substrates) (protein specific)
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O
Staphylococcus aureus
2 AMP
?
Substrates and Products (Substrate) (protein specific)
5'-O-phosphonoadenylyl-(3'->5')-adenosine + H2O
751077
Staphylococcus aureus
2 AMP
?
additional information
Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP
751077
Staphylococcus aureus
?
additional information
Pde2 is capable of hydrolyzing c-di-AMP, but5 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. No substrate: ATP
751077
Staphylococcus aureus USA300
?
General Information
physiological function
a Pde2 mutant strain displays a growth defect in the early growth phase. The mutant displays an increase in cellular c-di-AMP and 5'-O-phosphonoadenylyl-(3'->5')-adenosine levels and increased oxacillin resistance. A strain producing a high level of c-di-AMP has increased and a stain producing low levels has decreased acid resistance
Staphylococcus aureus
General Information (protein specific)
physiological function
a Pde2 mutant strain displays a growth defect in the early growth phase. The mutant displays an increase in cellular c-di-AMP and 5'-O-phosphonoadenylyl-(3'->5')-adenosine levels and increased oxacillin resistance. A strain producing a high level of c-di-AMP has increased and a stain producing low levels has decreased acid resistance
Staphylococcus aureus
Other publictions for EC
751077
Bowman
New insights into the cyclic ...
Staphylococcus aureus
J. Biol. Chem.
291
26970-26986
2016
-
-
-
-
-
-
1
-
-
-
-
1
-
1
-
-
-
-
-
-
-
-
3
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
1
-
-
-
-
-
-
-
-
3
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
750844
Tang
Functional analysis of a c-di ...
Mycolicibacterium smegmatis, Mycolicibacterium smegmatis ATCC 700084
Int. J. Biol. Sci.
11
813-824
2015
-
-
-
-
2
-
-
-
-
4
-
4
-
2
-
-
-
-
-
-
-
-
4
-
2
2
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
4
-
4
-
-
-
-
-
-
-
-
4
-
2
-
-
-
1
-
-
-
-
1
1
-
-
-
750731
Ye
DhhP, a cyclic di-AMP phospho ...
Borreliella burgdorferi, Borreliella burgdorferi DSM 4680
Infect. Immun.
82
1840-1849
2014
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
1
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
1
1
-
-
-
750954
Bai
Two DHH subfamily 1 proteins ...
Streptococcus pneumoniae serotype 2, Streptococcus pneumoniae serotype 2 D39
J. Bacteriol.
195
5123-5132
2013
-
-
-
-
-
-
-
1
1
1
-
-
-
2
-
-
-
-
-
-
-
-
5
2
2
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
1
-
-
-
-
-
-
-
-
-
-
5
2
-
-
-
-
1
-
-
-
-
1
1
-
-
-